Why It Matters
Massachusetts faces a significant gap in primary care access, with roughly 750,000 adults in the state lacking a regular source of medical care. A proposed affiliation between CVS Health and Mass General Brigham could help fill that gap — but regulators are raising alarms about what it might cost insured patients and employers in the process.
What Happened
The Massachusetts Health Policy Commission is set to release its final review of the proposed CVS Health and Mass General Brigham (MGB) affiliation on June 11. The arrangement would bring approximately 80 nurse practitioners working at 37 CVS MinuteClinic locations across the state into MGB’s clinical network and accountable care organization.
Supporters of the deal argue it would expand primary care access in a state where demand far outstrips supply. Under the arrangement, CVS and MGB project that roughly 34,000 patients could receive primary care services through MinuteClinic within three years, with the potential to eventually reach as many as 120,000 adults.
The Health Policy Commission’s preliminary review, released in April, found that the affiliation could add more than $40 million annually to commercial health care spending by its third year of operation. CVS and MGB have contested that figure, offering their own estimate of between $13 million and $22 million per year in additional costs.
By the Numbers
Even under the parties’ own lower estimates, the analysis reveals a notable concern: approximately $10 million of the projected cost increase would result from higher reimbursement rates rather than any growth in the number of patients treated. Commercial insurance reimbursement for nurse practitioner visits would rise by an average of 129 percent if the affiliation moves forward — a direct consequence of MinuteClinic joining MGB’s higher-priced network.
Currently, 81 percent of MinuteClinic visits in Massachusetts are paid through commercial insurance. CVS has also stated it does not plan to immediately participate as a primary care provider in MassHealth, the state’s Medicaid program, raising questions about whether the expansion would meaningfully benefit lower-income residents.
By comparison, more than 75 percent of other primary care practices in Massachusetts have participated in a population-based payment model since 2023 — a structure designed to control costs by tying reimbursement to outcomes rather than volume.
Access Gains vs. Cost Concerns
The debate captures a tension familiar in health policy: how to expand access to care without accelerating the price increases that have long burdened Massachusetts consumers and employers. The state already has among the highest health care costs in the nation, and Mass General Brigham — as the state’s largest hospital system — has drawn scrutiny in past years for its pricing practices.
The proposed affiliation also includes a provision that would eliminate pediatric visits, other than vaccinations, for children over age five. That restriction could limit the deal’s broader public health value, particularly in communities that rely on MinuteClinic for accessible care.
For context on the broader political environment surrounding Massachusetts health and economic policy, see our coverage of Governor Healey’s standing in recent polling.
Zoom Out
Across the country, retail clinic networks have positioned themselves as a solution to primary care shortages, particularly in areas where physician practices are at capacity. Several states have seen similar debates about whether integrating retail clinics into large health system networks expands access or simply transplants high prices into lower-cost settings.
Massachusetts voters are already facing a crowded policy landscape this fall, with as many as 11 ballot measures under consideration that could shape state health and economic priorities heading into 2027.
What’s Next
The Health Policy Commission’s June 11 final review will determine whether the agency recommends approving, modifying, or blocking the affiliation. Regulators can attach conditions to any approval, which could include requirements for MassHealth participation, price constraints, or commitments to maintain pediatric services. CVS and Mass General Brigham are expected to respond to the final findings before any formal determination takes effect.